Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway

Proceedings of the National Academy of Sciences of the United States of America
Christian KorherrUlrich Brinkmann

Abstract

A genome-wide phenotype screen was used to identify factors and pathways that induce proliferation of human umbilical vein endothelial cells (HUVEC). HUVEC proliferation is a recognized marker for factors that modulate vascularization. Screening "hits" included known proangiogenic factors, such as VEGF, FGF1, and FGF2 and additional factors for which a direct association with angiogenesis was not previously described. These include the kinase TBK1 as well as Toll-like receptor adaptor molecule and IFN regulatory factor 3. All three proteins belong to one signaling pathway that mediates induction of gene expression, including a mixture of secreted factors, which, in concert, mediate proliferative activity toward endothelial cells. TBK1 as the "trigger" of this pathway is induced under hypoxic conditions and expressed at significant levels in many solid tumors. This pattern of expression and the decreased expression of angiogenic factors in cultured cells upon RNA-interference-mediated ablation suggests that TBK1 is important for vascularization and subsequent tumor growth and a target for cancer therapy.

References

Aug 1, 1993·Nature Genetics·M S BoguskiC M Tolstoshev
Jan 5, 1999·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·M Bar-Eli
Jan 23, 1999·Nature Genetics·R J LipshutzD J Lockhart
Mar 31, 2000·Nature Medicine·P Carmeliet
Jun 6, 2000·Critical Reviews in Oncology/hematology·P GerwinsL Claesson-Welsh
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R SalcedoJ J Oppenheim
Feb 22, 2001·Science·J C VenterX Zhu
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Jul 19, 2001·Journal of the National Cancer Institute·I J Fidler
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kathy BoonGregory J Riggins
Oct 3, 2002·Nature Reviews. Cancer·Napoleone Ferrara
Jan 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kristi A EglandIra Pastan
Mar 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Aihua LiRakesh K Singh
Apr 15, 2003·Nature Immunology·Katherine A FitzgeraldTom Maniatis
Dec 23, 2003·Immunology Letters·Evan P AdlerRobert A Kurt
Jul 2, 2004·Nature Reviews. Cancer·Fran Balkwill
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Kerstin Koenig-HoffmannUlrich Brinkmann
Dec 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Miwa SasaiTsukasa Seya

❮ Previous
Next ❯

Citations

Dec 18, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Johannes KluweRobert F Schwabe
Sep 12, 2012·Inflammopharmacology·J M MadeiraA Klegeris
Feb 13, 2010·Molecular Biotechnology·W Frank An, Nicola Tolliday
Jan 23, 2009·Cell Research·Jean-François ClémentMarc J Servant
Jan 26, 2008·Nature Reviews. Cancer·Brian O Bodemann, Michael A White
Nov 3, 2010·Oncogene·R R Shen, W C Hahn
Feb 20, 2007·Molecular BioSystems·Shiro Tochitani, Yoshihide Hayashizaki
Feb 4, 2010·Tissue Engineering. Part B, Reviews·Lauren S SefcikEdward A Botchwey
Sep 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dung-Fang Lee, Mien-Chie Hung
Mar 6, 2007·PLoS Pathogens·Andrea L RadtkeMary X D O'Riordan
Feb 18, 2010·Therapy·Sapna Trivedi, Eric L Greidinger
Feb 4, 2014·Cell Death and Differentiation·K ShostakA Chariot
Mar 7, 2014·Cardiovascular Research·Shu-Min ZhangHongliang Li
Mar 3, 2007·Expert Review of Molecular Diagnostics·Vivek Mittal, Daniel J Nolan
Jan 18, 2011·Critical Reviews in Oncology/hematology·Jahangir AbdiFrank Redegeld
Jan 24, 2012·International Journal of Experimental Pathology·Helle Bielefeldt-OhmannThomas R Hansen
Feb 7, 2012·Journal of Cellular Physiology·Kiran Mahajan, Nupam P Mahajan
Sep 20, 2012·Journal of Cellular Biochemistry·Jing LinJianming Cai
Jul 30, 2011·British Journal of Pharmacology·Carly GambleAndrew Paul
May 12, 2009·Biochemical Pharmacology·Jun Kyung LeeJoo Young Lee
Aug 30, 2013·Expert Opinion on Therapeutic Targets·Jae-Young KimEric B Haura
Mar 27, 2012·Expert Opinion on Therapeutic Targets·Carmine Carbone, Davide Melisi
Jan 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Congwen WeiHui Zhong
Jul 23, 2013·The American Journal of Pathology·Monica LoganSarki A Abdulkadir
Nov 1, 2016·Journal of Neurochemistry·Li-Chun WangGuillermina Almazan
Apr 2, 2019·Journal of Cellular and Molecular Medicine·Karin H SimonsPaul H A Quax
Apr 3, 2019·JCI Insight·Victoria H CruzRolf A Brekken
Mar 27, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yanyu ZhangAnna-Karin Olsson
May 5, 2016·Oncotarget·Seung Eun LeeKyoung-Mee Kim
May 28, 2020·Acta Biochimica Et Biophysica Sinica·Ruyuan ZhouPinglong Xu
Sep 24, 2020·Expert Opinion on Therapeutic Targets·Or-Yam RevachRussell W Jenkins
Feb 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Subhra K BiswasClaire E Lewis
Sep 14, 2007·The Biochemical Journal·Jenny BainPhilip Cohen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.